Financial Year |
March 31 2023 |
Monetary Funds |
244,124,898.71 |
Held-for-trading Financial Assets |
370,000,000.00 |
Notes Receivable |
2,944,112.88 |
Accounts Receivable |
134,412,633.39 |
Advances to Suppliers |
2,219,266.98 |
Other Receivables |
297,352.58 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
104,616,128.32 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
860,842.56 |
Total Current Assets |
900,513,051.38 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
192,967,844.39 |
Under-construction Projects |
7,203,097.53 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
31,395,196.90 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
2,650,287.24 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
234,216,426.06 |
Total Assets |
1,134,729,477.44 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
54,338,023.19 |
Accounts Payable |
83,403,750.40 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
4,457,158.28 |
Taxes Payable |
1,600,889.77 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
1,550,959.83 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
325,845.91 |
Sub-Total of Current Liabilities |
147,875,844.40 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
5,981,250.00 |
Total Liabilities |
153,857,094.40 |
Paid-In Capital(Or Share Stock) |
120,000,000.00 |
Capital Surplus |
412,437,390.75 |
Surplus Reserve |
48,262,407.69 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
395,805,947.76 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
980,872,383.04 |
Owner's Equity(Stockholder's Equity) |
980,872,383.04 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,134,729,477.44 |